5MY0 image
Deposition Date 2017-01-25
Release Date 2018-01-24
Last Version Date 2024-01-17
Entry Detail
PDB ID:
5MY0
Keywords:
Title:
KS-MAT DI-DOMAIN OF MOUSE FAS WITH MALONYL-COA
Biological Source:
Source Organism:
Mus musculus (Taxon ID: 10090)
Method Details:
Experimental Method:
Resolution:
2.94 Å
R-Value Free:
0.22
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
C 2 2 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Fatty acid synthase
Gene (Uniprot):Fasn
Chain IDs:A, D
Chain Length:852
Number of Molecules:2
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Molecule:Fatty acid synthase
Gene (Uniprot):Fasn
Chain IDs:B, C
Chain Length:852
Number of Molecules:2
Biological Source:Mus musculus
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
K5L A SER modified residue
Primary Citation
Characterization of the Polyspecific Transferase of Murine Type I Fatty Acid Synthase (FAS) and Implications for Polyketide Synthase (PKS) Engineering.
ACS Chem. Biol. 13 723 732 (2018)
PMID: 29328619 DOI: 10.1021/acschembio.7b00718

Abstact

Fatty acid synthases (FASs) and polyketide synthases (PKSs) condense acyl compounds to fatty acids and polyketides, respectively. Both, FASs and PKSs, harbor acyltransferases (ATs), which select substrates for condensation by β-ketoacyl synthases (KSs). Here, we present the structural and functional characterization of the polyspecific malonyl/acetyltransferase (MAT) of murine FAS. We assign kinetic constants for the transacylation of the native substrates, acetyl- and malonyl-CoA, and demonstrate the promiscuity of FAS to accept structurally and chemically diverse CoA-esters. X-ray structural data of the KS-MAT didomain in a malonyl-loaded state suggests a MAT-specific role of an active site arginine in transacylation. Owing to its enzymatic properties and its accessibility as a separate domain, MAT of murine FAS may serve as versatile tool for engineering PKSs to provide custom-tailored access to new polyketides that can be applied in antibiotic and antineoplastic therapy.

Legend

Protein

Chemical

Disease

Primary Citation of related structures